Market Recap — July 29, 2026
Today's running recap of insider activity, SEC filings, and market-moving news. Updates throughout the trading day.
Last updated Jul 29, 2026, 6:18 AM ET · updates through the trading day
Top Importance Today
Filings and news with the highest AI-ranked importance score.
Biogen Tops Q2 Estimates but Slashes Full-Year EPS Outlook by ~15%, Citing Apellis Dilution and Pipeline Costs
Generac obliterates Q2 estimates and lifts margin guidance as the data center boom accelerates
Biogen Slashes 2026 Profit Outlook Despite Q2 Beat, Shares Tumble
UBS Posts $2.8B Q2 Profit, Raises Buyback to $3B, Sees 2026 Targets Beat
Alphabet Capex Hits $200B, FCF Turns Negative; $10B EU DMA Risk Looms
Visa Raises Guidance, Cuts 2,600 Jobs in AI Restructuring
Lemonade Q2 Revenue Jumps 79%, Guides for Positive EBITDA by Q4
ArcBest Q2 Revenue Rises 16% to $1.18B, Beating Estimates on Higher Shipment Weights
Generac Q2 Adjusted EPS Soars to $2.91, Raises EBITDA Margin Outlook
LXP Suspends Dividend, Posts Q2 Revenue Growth Amid $5.2B Buyout
Woodside Q2 Revenue Jumps 28% to $4.2B; Scarborough 98% Complete, First Gas Achieved
Lemonade Posts $0.56 Q2 Loss Per Share, Missing Expectations
Largest Open-Market Insider Buys
Form 4 open-market purchases ranked by dollar amount.
No open-market insider buys reported on this date.
Largest Open-Market Insider Sells
Form 4 open-market sales ranked by dollar amount.
No open-market insider sells reported on this date.
Notable 8-Ks and News
Material events and breaking news with importance score 6 or higher.
Biogen Tops Q2 Estimates but Slashes Full-Year EPS Outlook by ~15%, Citing Apellis Dilution and Pipeline Costs
Generac obliterates Q2 estimates and lifts margin guidance as the data center boom accelerates
Biogen Slashes 2026 Profit Outlook Despite Q2 Beat, Shares Tumble
UBS Posts $2.8B Q2 Profit, Raises Buyback to $3B, Sees 2026 Targets Beat
Alphabet Capex Hits $200B, FCF Turns Negative; $10B EU DMA Risk Looms
Visa Raises Guidance, Cuts 2,600 Jobs in AI Restructuring
Lemonade Q2 Revenue Jumps 79%, Guides for Positive EBITDA by Q4
ArcBest Q2 Revenue Rises 16% to $1.18B, Beating Estimates on Higher Shipment Weights
Generac Q2 Adjusted EPS Soars to $2.91, Raises EBITDA Margin Outlook
LXP Suspends Dividend, Posts Q2 Revenue Growth Amid $5.2B Buyout
Form 144 Notices
Notices that restricted shares may be sold soon — often a precursor to insider selling.
No Form 144 notices filed on this date.
Day boundary: 00:00 ET (America/New_York). Filings accepted late may appear in the next day's recap.